Oncternal Therapeutics, Inc. (ONCT) Social Stream
ONCTERNAL THERAPEUTICS INC (ONCT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ONCT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-26 | 4 | $21 | $9 | $15.5 | $0.536 | 2791.79% |
| 2022-05-06 | 4 | $16 | $9 | $14 | $0.536 | 2511.94% |
| 2022-05-27 | 5 | $15 | $8 | $12.25 | $0.536 | 2185.45% |
| 2022-07-15 | 5 | $15 | $3.5 | $10.5 | $0.536 | 1858.96% |
| 2022-09-27 | 5 | $15 | $3.5 | $10.3 | $0.536 | 1821.64% |
| 2022-12-12 | 4 | $15 | $3.5 | $9.875 | $0.536 | 1742.35% |
| 2022-12-22 | 5 | $15 | $3.5 | $8.7 | $0.536 | 1523.13% |
| 2023-03-10 | 6 | $15 | $3.5 | $8.7 | $0.536 | 1523.13% |
| 2023-03-14 | 5 | $15 | $3.5 | $8.25 | $0.536 | 1439.18% |
| 2023-03-22 | 6 | $15 | $3.5 | $7.416 | $0.536 | 1283.58% |
| 2023-04-04 | 6 | $4 | $2.5 | $3.333 | $0.536 | 521.83% |
| 2023-08-14 | 6 | $2.5 | $1.3 | $1.9 | $0.536 | 254.48% |
| 2023-09-18 | 6 | $2.5 | $1.3 | $1.933 | $0.536 | 260.63% |
| 2023-10-27 | 5 | $2.5 | $2 | $2.25 | $0.536 | 319.78% |
| 2023-11-10 | 4 | $2.5 | $2 | $2.25 | $0.536 | 319.78% |
| 2023-12-04 | 4 | $2.5 | $2 | $2.166 | $0.536 | 304.1% |
The Trend in the Analyst Price Target
ONCT's average price target has moved down $8.33 over the prior 57 months.
Over the past 38 weeks, ONCT's average upside potential has been 690.43%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-10 | 6 | 15.0 | 3.5 | 8.250 | 0.750 | 1000% |
| 2023-03-14 | 5 | 15.0 | 3.5 | 8.250 | 0.738 | 1017.89% |
| 2023-03-22 | 6 | 15.0 | 3.5 | 7.416 | 0.706 | 950.42% |
| 2023-05-05 | 6 | 2.5 | 1.3 | 1.900 | 0.330 | 475.76% |
| 2023-10-27 | 5 | 2.5 | 2.0 | 2.250 | 0.320 | 603.12% |
ONCT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 3 | 0 | 1 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 31 weeks, ONCT's average broker recommendation rating improved by 1.17.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how ONCTERNAL THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1822.79% of that group.
- In terms of how ONCTERNAL THERAPEUTICS INC fares relative to all US stocks, note that its average analyst price target is greater than 140.54% of that group.
- ONCT has a lower variance in analysts' estimates than -1284.59% of stocks in the small market cap category.
- In the context of Healthcare stocks, ONCTERNAL THERAPEUTICS INC's number of analysts covering the stock is higher than 511.11% of them.
In the Pharmaceutical Products industry, MTEM, LUMO, and CPIX are the three stocks most similar to ONCTERNAL THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for ONCT? Use POWR Ratings for clearer insight into price direction.